Evidence map›Paper›PMID 22850880›Full record

ReviewThe Journal of clinical investigation2012

Alarmins: awaiting a clinical response.

James K Chan, Johannes Roth, Joost J Oppenheim, Kevin J Tracey, Thomas Vogl, Marc Feldmann, Nicole Horwood, Jagdeep Nanchahal

Abstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 258 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
258citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

258 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Rutin attenuates liver fibrosis via the IRG1-itaconate-Nrf2 axis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Zinc-EnrichedNutrients · 2025
    Article

198 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

James K ChanKennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom. james.chan@kennedy.ox.ac.uk
Johannes Roth
Joost J Oppenheim
Kevin J Tracey
Thomas Vogl
Marc Feldmann
Nicole Horwood
Jagdeep Nanchahal

Funding

Studies of Receptor Interactions and Effects of AlarminsZIABC009369 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OPPENHEIM, JOOST J · 2009 to 2022
$16.5M
HMG IN POST OPERATIVE AND TRAUMATIC STRESSR01GM062508 · NIGMS · NORTH SHORE UNIVERSITY HOSPITAL · PI TRACEY, KEVIN J · 2001 to 2014
$3.7M
NIGMS NIH HHS R01 GM062508Wellcome Trust 096035
6 · The paper itself

Abstract

Alarmins are endogenous molecules that are constitutively available and released upon tissue damage and activate the immune system. Current evidence indicates that uncontrolled and excessive release of alarmins contributes to the dysregulated processes seen in many inflammatory and autoimmune conditions, as well as tumorigenesis and cancer spread. Conversely, alarmins have also been found to play a major role in the orchestration of tissue homeostasis, including repair and remodeling in the heart, skin, and nervous system. Here, we provide an update and overview on alarmins, highlighting the areas that may benefit from this clinical translation.

Indexed as

Adaptive ImmunityAnimalsAutoimmune DiseasesBiomarkersHumansImmunity, InnateInflammationInflammation MediatorsNeoplasmsRegenerative MedicineSepsisSignal TransductionSystemic Inflammatory Response SyndromeBiomarkersInflammation Mediators

Identifiers

PMID22850880
PMCPMC3408740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.